Keyphrases
Clinical Trials
100%
Insulin-like Growth Factor 1 Receptor (IGF1R)
100%
Receptor Antagonist
100%
Cancer Therapy
100%
Growth Factors
57%
Insulin-like
57%
Therapeutic Target
28%
Chemotherapy
14%
Cell Surface
14%
Biological Activity
14%
Therapeutic Goals
14%
Oncology
14%
In Cancer
14%
Expert Opinion
14%
Area Cover
14%
Malignant Transformation
14%
Anti-apoptotic
14%
Pro-survival
14%
Signaling Cascades
14%
Tyrosine Kinase
14%
Patient Selection
14%
Receptor Targets
14%
Survivability
14%
Cytoplasmic Signalling
14%
Heterotetramer
14%
Personalized Medicine
14%
Biological Agents
14%
Peptide Hormone
14%
Phase II Trial
14%
Small Molecular Weight Inhibitors
14%
Secreted Peptides
14%
Predictive Biomarker
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Malignant Neoplasm
100%
Receptor
100%
Insulin-Like Growth Factor 1
100%
Somatomedin
57%
Biological Marker
14%
Chemotherapy
14%
Malignant Transformation
14%
Protein Tyrosine Kinase
14%
Antiapoptotic
14%
Biological Product
14%
Receptor Antibody
14%
Biological Activity
14%
Peptide Hormone
14%